Halozyme Therapeutics shares owned by Henderson Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Henderson Group
from 13F filings
Historical chart of Henderson Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Henderson Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $70M | 958k | 73.33 |
| 2025-03-31 | $46M | 715k | 63.84 |
| 2024-12-31 | $34M | 702k | 47.81 |
| 2024-09-30 | $31M | 545k | 57.24 |
| 2024-06-30 | $27M | 513k | 52.37 |
| 2024-03-31 | $22M | 531k | 40.68 |
| 2023-12-31 | $16M | 428k | 36.96 |
| 2023-09-30 | $16M | 427k | 38.20 |
| 2023-06-30 | $15M | 428k | 36.07 |
| 2023-03-31 | $16M | 428k | 38.19 |
| 2022-12-31 | $37M | 644k | 56.90 |
| 2022-09-30 | $28M | 690k | 40.00 |
| 2022-03-31 | $29M | 730k | 39.55 |
| 2021-12-31 | $27M | 672k | 40.21 |
| 2021-09-30 | $27M | 658k | 40.68 |
| 2021-06-30 | $30M | 652k | 45.41 |
| 2021-03-31 | $29M | 683k | 41.69 |
| 2020-12-31 | $34M | 799k | 42.71 |
| 2020-09-30 | $23M | 889k | 26.28 |